JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Davison, C.
Right arrow Articles by Smith, P. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Davison, C.
Right arrow Articles by Smith, P. K.
Journal of Pharmacology And Experimental Therapeutics, Vol. 133, Issue 2, 161-170, 1961
Copyright © 1961 by American Society for Pharmacology and Experimental Therapeutics


THE BINDING OF SALICYLIC ACID AND RELATED SUBSTANCES TO PURIFIED PROTEINS

Clarke Davison 1 and Paul K. Smith 1

1 Department of Pharmacology, The George Washington University School of Medicine, Washington, D. C.

The binding of a series of simple derivatives of benzoic acid to bovine serum albumin has been investigated. Drugs such as salicylic acid and ggr-resorcylic acid exhibit extensive binding, while p-aminosalicylate, gentisate, p-aminobenzoate, salicylamide and acetylsalicylate show little or no interaction. The carboxylic acid group confers the primary binding capacity upon the compounds, but the presence of ortho hydrogen donors or of alkyl substitution may enhance this capacity. Hydrogen donors in the meta or para position decrease binding. Most of the compounds exhibit two types of binding sites, one of relatively high affinity but small in number, a second of low affinity but in greater number. The former appears to be more structure specific.

The nature of the binding sites upon the protein has been investigated by the use of changes in hydrogen ion concentration, and of chemically modified proteins. The binding appears to be predominantly to the epsilon-amino and possibly the guanidino groups of the protein molecule.

Submitted on February 4, 1961







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1961 by the American Society for Pharmacology and Experimental Therapeutics.